Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | President & COO | July 24, 2018 | July 25, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date July 24, 2018 · Filed July 25, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,155 |
Ending reported balance
After 2018-07-24 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2018-07-24 · Exercise / conversion · Acquired 5,474 · Balance 27,553 Row 2 · 2018-07-24 · Exercise / conversion · Acquired 8,375 · Balance 35,928 Row 3 · 2018-07-24 · Sale · Disposed 18,773 · Balance 17,155 F1: This sale occurred pursuant to a 10b5-1 Trading Plan. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.41 · Expires 2021-02-28 | Direct | 0 |
Reported balance
After 2018-07-24 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-07-24 · Exercise / conversion · Disposed 5,474 · Balance 0 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.70 · Expires 2021-02-26 | Direct | 16,749 |
Reported balance
After 2018-07-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-07-24 · Exercise / conversion · Disposed 8,375 · Balance 16,749 |
| Common StockSEC Table I · non-derivative | IndirectBy Revocable Trust | 40,748 |
Reported balance
Holding disclosure · report date 2018-07-24 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 40,748 |
Filing footnotes · ownership attribution and instrument terms
F1: This sale occurred pursuant to a 10b5-1 Trading Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 210 | $108.01 | $22,682.10 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 10 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,196 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $108.01 | $10,800.50 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 9 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,406 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $108.00 | $32,400.00 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 8 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,506 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $108.00 | $1,079.95 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 7 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,806 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.99 | $21,598.00 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 6 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,816 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $107.99 | $32,395.50 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 5 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,016 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 90 | $107.98 | $9,718.20 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,316 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $107.97 | $32,391.00 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 3 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,406 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.95 | $21,589.00 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,706 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.93 | $21,586.00 |
DisclosureSEC source: 0001127602-17-027114 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,906 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 8,374 | $0.00 Strike: $73.70 | $0.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · derivative · entry 31 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,124 Underlying: Common Stock · 8,374 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,165 | $0.00 Strike: $76.67 | $0.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · derivative · entry 30 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,495 Underlying: Common Stock · 6,165 shares Expires 2020-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.89 | $10,789.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 29 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,106 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.87 | $10,787.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 28 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,206 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.85 | $10,785.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 27 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,306 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.85 | $21,569.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 26 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,406 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $107.84 | $53,920.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 25 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,606 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.78 | $10,778.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 24 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,106 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.71 | $10,771.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 23 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,206 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $107.64 | $43,056.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 22 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,306 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $107.63 | $107.63 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 21 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,706 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $107.63 | $1,076.25 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 20 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,707 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $107.59 | $43,036.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 19 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,717 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $107.58 | $43,032.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 18 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,117 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.58 | $10,757.50 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 17 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,517 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.57 | $21,514.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 16 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,617 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 600 | $107.55 | $64,530.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 15 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,817 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $107.52 | $32,256.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 14 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,417 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $107.51 | $32,253.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 13 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,717 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.50 | $10,750.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 12 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,017 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $107.49 | $42,996.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 11 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,117 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 153 | $107.46 | $16,441.38 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 10 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,517 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $107.45 | $32,235.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 9 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,670 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 218 | $107.43 | $23,419.74 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 8 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,970 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.33 | $10,733.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 7 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,188 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $107.26 | $32,178.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 6 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,288 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.24 | $21,448.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 5 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,588 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $107.20 | $10,720.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,788 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $107.17 | $21,434.00 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 3 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,888 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 8,374 | $73.70 | $617,163.80 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 12:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 6,165 | $76.67 | $472,670.55 |
DisclosureSEC source: 0001127602-17-027112 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 10,948 | $0.00 Strike: $59.41 | $0.00 |
DisclosureSEC source: 0001127602-17-022067 · form4.xml · derivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,474 Underlying: Common Stock · 10,948 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10,948 | $100.00 | $1,094,800.00 |
DisclosureSEC source: 0001127602-17-022067 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,549 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 10,948 | $59.41 | $650,420.68 |
DisclosureSEC source: 0001127602-17-022067 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,474 | $0.00 Strike: $59.41 | $0.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · derivative · entry 31 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,422 Underlying: Common Stock · 5,474 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,502 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · derivative · entry 30 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,502 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 203 | $92.93 | $18,864.79 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 28 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,549 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $92.92 | $46,460.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 27 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,752 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 604 | $92.91 | $56,117.64 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 26 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,252 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $92.91 | $9,290.50 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 25 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,856 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.